Cargando…
Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike protein to overcome viral variants
Most therapeutic mAbs target the receptor-binding domain (RBD) of the spike protein of SARS-CoV-2. Unfortunately, the RBD is a hot spot for mutations in SARS-CoV-2 variants, which will lead to loss of the neutralizing function of current therapeutic mAbs. Universal mAbs for different variants are ne...
Autores principales: | Wu, Wan-Ling, Chiang, Chen-Yi, Lai, Szu-Chia, Yu, Chia-Yi, Huang, Yu-Ling, Liao, Hung-Chun, Liao, Ching-Len, Chen, Hsin-Wei, Liu, Shih-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089791/ https://www.ncbi.nlm.nih.gov/pubmed/35290246 http://dx.doi.org/10.1172/jci.insight.157597 |
Ejemplares similares
-
Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy
por: Chiang, Chen-Yi, et al.
Publicado: (2022) -
Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants
por: Wang, Hsin-I, et al.
Publicado: (2021) -
Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity
por: Liao, Hung-Chun, et al.
Publicado: (2022) -
Intranasal Vaccination With Recombinant Antigen-FLIPr Fusion Protein Alone Induces Long-Lasting Systemic Antibody Responses and Broad T Cell Responses
por: Hsieh, Ming-Shu, et al.
Publicado: (2021) -
Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV)
por: Lai, Szu-Chia, et al.
Publicado: (2005)